Literature DB >> 25524106

Modularized CRISPR/dCas9 effector toolkit for target-specific gene regulation.

Michael Agne1, Ilona Blank, Alica J Emhardt, Christoph G Gäbelein, Fenja Gawlas, Nadine Gillich, Patrick Gonschorek, Thomas J Juretschke, Stefan D Krämer, Natalie Louis, Anne Müller, Alina Rudorf, Lisa M Schäfer, Manuel C Scheidmann, Lisa J Schmunk, Philipp M Schwenk, Maximilian R Stammnitz, Philipp M Warmer, Wilfried Weber, Adrian Fischer, Beate Kaufmann, Hanna J Wagner, Gerald Radziwill.   

Abstract

The ability to control mammalian genes in a synergistic mode using synthetic transcription factors is highly desirable in fields of tissue engineering, stem cell reprogramming and fundamental research. In this study, we developed a standardized toolkit utilizing an engineered CRISPR/Cas9 system that enables customizable gene regulation in mammalian cells. The RNA-guided dCas9 protein was implemented as a programmable transcriptional activator or repressor device, including targeting of endogenous loci. For facile assembly of single or multiple CRISPR RNAs, our toolkit comprises a modular RNAimer plasmid, which encodes the required noncoding RNA components.

Entities:  

Mesh:

Year:  2014        PMID: 25524106     DOI: 10.1021/sb500035y

Source DB:  PubMed          Journal:  ACS Synth Biol        ISSN: 2161-5063            Impact factor:   5.110


  13 in total

1.  Adenovirus-Mediated Somatic Genome Editing of Pten by CRISPR/Cas9 in Mouse Liver in Spite of Cas9-Specific Immune Responses.

Authors:  Dan Wang; Haiwei Mou; Shaoyong Li; Yingxiang Li; Soren Hough; Karen Tran; Jia Li; Hao Yin; Daniel G Anderson; Erik J Sontheimer; Zhiping Weng; Guangping Gao; Wen Xue
Journal:  Hum Gene Ther       Date:  2015-07       Impact factor: 5.695

Review 2.  Targeting cancer epigenetics with CRISPR-dCAS9: Principles and prospects.

Authors:  Mohammad Mijanur Rahman; Trygve O Tollefsbol
Journal:  Methods       Date:  2020-04-18       Impact factor: 3.608

Review 3.  Congenital diarrhoeal disorders: advances in this evolving web of inherited enteropathies.

Authors:  Roberto Berni Canani; Giuseppe Castaldo; Rosa Bacchetta; Martín G Martín; Olivier Goulet
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2015-03-17       Impact factor: 73.082

Review 4.  Targeting HIV-1 proviral transcription.

Authors:  Alex Olson; Binita Basukala; Wilson W Wong; Andrew J Henderson
Journal:  Curr Opin Virol       Date:  2019-08-29       Impact factor: 7.121

5.  CRISPR/gRNA-directed synergistic activation mediator (SAM) induces specific, persistent and robust reactivation of the HIV-1 latent reservoirs.

Authors:  Yonggang Zhang; Chaoran Yin; Ting Zhang; Fang Li; Wensheng Yang; Rafal Kaminski; Philip Regis Fagan; Raj Putatunda; Won-Bin Young; Kamel Khalili; Wenhui Hu
Journal:  Sci Rep       Date:  2015-11-05       Impact factor: 4.379

Review 6.  Signaling in T cells - is anything the m(a)TOR with the picture(s)?

Authors:  Mark Boothby
Journal:  F1000Res       Date:  2016-02-18

Review 7.  Epigenetic Editing: On the Verge of Reprogramming Gene Expression at Will.

Authors:  David Cano-Rodriguez; Marianne G Rots
Journal:  Curr Genet Med Rep       Date:  2016-10-01

8.  Engineered BRET-Based Biologic Light Sources Enable Spatiotemporal Control over Diverse Optogenetic Systems.

Authors:  Kshitij Parag-Sharma; Colin P O'Banion; Erin C Henry; Adele M Musicant; John L Cleveland; David S Lawrence; Antonio L Amelio
Journal:  ACS Synth Biol       Date:  2019-12-17       Impact factor: 5.110

Review 9.  Epigenetic Editing in Prostate Cancer: Challenges and Opportunities.

Authors:  Mariana Brütt Pacheco; Vânia Camilo; Rui Henrique; Carmen Jerónimo
Journal:  Epigenetics       Date:  2021-06-15       Impact factor: 4.861

10.  Comprehensive off-target analysis of dCas9-SAM-mediated HIV reactivation via long noncoding RNA and mRNA profiling.

Authors:  Yonggang Zhang; Gustavo Arango; Fang Li; Xiao Xiao; Raj Putatunda; Jun Yu; Xiao-Feng Yang; Hong Wang; Layne T Watson; Liqing Zhang; Wenhui Hu
Journal:  BMC Med Genomics       Date:  2018-09-10       Impact factor: 3.063

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.